Advances in immunotherapies and targeted treatments for patients with bladder cancer: An update from ESMO 2022

touchPODCAST · Oct 3, 2022 · 58m

touchCONGRESS for touchONCOLOGY

Listen to urological cancer expert Prof. Axel Merseburger (Germany) review key data presented at ESMO 2022 exploring recent advances in immunotherapies and targeted treatments for patients with bladder cancer. He then offers his views on the potential impact of these data on clinical practice, alongside expert insights from Dr Bradley McGregor (USA) and Prof. Andrea Necchi (Italy).

OVERVIEW

Data Review with Prof. Merseburger (00:00)

Expert interviews with Prof. Merseburger, Dr McGregor and Prof. Necchi answering the questions below

INTERVIEW QUESTIONS

Based on…